Utility of dobutamine stress echocardiography as part of the pre-liver transplant evaluation: An evaluation of its efficacy

Clinical Cardiology

Volumn 37, Issue 8, 2014, Pages 468-472

  Snipelisky, David ^a   Levy, Michael ^a   Shapiro, Brian ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOBUTAMINE; BETA 1 ADRENERGIC RECEPTOR STIMULATING AGENT;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR MORTALITY; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; CONFIDENCE INTERVAL; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; END STAGE LIVER DISEASE; FEMALE; FOLLOW UP; HEART CATHETERIZATION; HUMAN; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; MORTALITY; PREDICTIVE VALUE; PREOPERATIVE EVALUATION; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; STRESS ECHOCARDIOGRAPHY; UNITED STATES; ADVERSE EFFECTS; CAUSE OF DEATH; COMPLICATION; CORONARY ANGIOGRAPHY; DECISION SUPPORT SYSTEM; ECHOGRAPHY; EVALUATION STUDY; FLORIDA; PREOPERATIVE CARE; RISK ASSESSMENT; RISK FACTOR; SEVERITY OF ILLNESS INDEX; TIME FACTOR; TREATMENT OUTCOME;

ADRENERGIC BETA-1 RECEPTOR AGONISTS; CAUSE OF DEATH; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; DECISION SUPPORT TECHNIQUES; DOBUTAMINE; ECHOCARDIOGRAPHY, STRESS; END STAGE LIVER DISEASE; FEMALE; FLORIDA; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 84906335285     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.22283     Document Type: Article

References (16)

1. Murray K, Carithers R Jr., AASLD practice guidelines: evaluation of the patient for liver transplantation. Hepatology. 2005; 41: 1407-1432.
2. Fleisher LA, Beckman JA, Brown KA, et al. 2009 ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology foundation/American Heart Association task force on practice guidelines. Circulation. 2009; 120: e169-e276.
3. Mandell MS, Lindenfield J, Tsou M, et al. Cardiac evaluation of liver transplant candidates. World J Gastroenterol. 2008; 14: 3445-3451.
4. Raval Z, Harinstein M, Skaro A, et al. Cardiovascular risk assessment of the liver transplant candidate. J Am Coll Cardiol. 2011; 58: 223-231.
5. Harinstein M, Flaherty J, Ansari A, et al. Predictive value of dobutamine stress echocardiography for coronary artery disease detection in liver transplant candidates. Am J Transplant. 2008; 8: 1523-1528.
6. Williams K, Lewis J, Davis G, et al. Dobutamine stress echocardiography in patients undergoing liver transplantation evaluation. Transplantation. 2000; 69: 2354-2356.
7. Keeffe B, Valantine H, Keeffe E,. Detection and treatment of coronary artery disease in liver transplant candidates. Liver Transpl. 2001; 7: 755-761.
8. Sawada SG, Segar DS, Ryan T, et al. Echocardiographic detection of coronary artery disease during dobutamine infusion. Circulation. 1991; 83: 1605-1614.
9. Umphrey L, Hurst R, Eleid M, et al. Preoperative dobutamine stress echocardiographic findings and subsequent short-term adverse cardiac events after orthotopic liver transplantation. Liver Transpl. 2008; 14: 886-892.
10. Findlay JY, Keegan MT, Pellikka PP, et al. Preoperative dobutamine stress echocardiography, intraoperative events, and intraoperative myocardial injury in liver transplantation. Transplant Proc. 2005; 37: 2209-2213.
11. Wolf A., Preoperative optimization of patients with liver disease. Curr Opin Anaesthesiol. 2005; 18: 325-331.
12. Donovan C, Marcovitz P, Punch J, et al. Two-dimensional and dobutamine stress echocardiography in the preoperative assessment of patients with end-stage liver disease prior to orthotopic liver transplantation. Transplantation. 1996; 61: 1180-1188.
13. Di Carli MF, Hachamovitch R,. New technology for noninvasive evaluation of coronary artery disease. Circulation. 2007; 115: 1464-1480.
14. Davidson C, Gheorghiade M, Flaherty J, et al. Predictive value of stress myocardial perfusion imaging in liver transplant candidates. Am J Cardiol. 100; 89: 359-360.
15. Moller S, Henriksen J,. Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease. Heart. 2002; 87: 9-15.
16. Tiukinhoy-Laing S, Rossi J, Bayram M, et al. Cardiac hemodynamic and coronary angiographic characteristics of patients being evaluated for liver transplantation. Am J Cardiol. 2006; 98: 178-181.